Announcement of Jiangsu Kangyuan Pharmaceutical Co., Ltd. on receiving the KYS202004A injection clinical trial approval notice

SZSI · Sep 6

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.